- Proven diagnosis of Ankylosing Spondylitisin accordance with local guidelines
- Patients treated as an outpatient
- Patients who suffer from hypersensitivity to the active substance Etanercept or to any
of the excipients of Enbrel®.
- Treatment with Enbrel® should not be initiated in patients with active infections
including chronic or localised infections.
- Patients with sepsis or risk of sepsis should not be treated.